+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?

Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?

Journal of Immunology Research 2017: 7904821

Aim. Evaluation of the impact of gut microflora on the pathophysiology of MS. Results. The etiopathogenesis of MS is not fully known. Gut microbiota may be of a great importance in the pathogenesis of MS, since recent findings suggest that substitutions of certain microbial population in the gut can lead to proinflammatory state, which can lead to MS in humans. In contrast, other commensal bacteria and their antigenic products may protect against inflammation within the central nervous system. The type of intestinal flora is affected by antibiotics, stress, or diet. The effects on MS through the intestinal microflora can also be achieved by antibiotic therapy and Lactobacillus. EAE, as an animal model of MS, indicates a strong influence of the gut microbiota on the immune system and shows that disturbances in gut physiology may contribute to the development of MS. Conclusions. The relationship between the central nervous system, the immune system, and the gut microbiota relates to the influence of microorganisms in the development of MS. A possible interaction between gut microbiota and the immune system can be perceived through regulation by the endocannabinoid system. It may offer an opportunity to understand the interaction comprised in the gut-immune-brain axis.

(PDF emailed within 0-6 h: $19.90)

Accession: 059625987

Download citation: RISBibTeXText

PMID: 28316999

DOI: 10.1155/2017/7904821

Related references

Impact of commensal microbiota on the host pathophysiology: focusing on immunity and inflammation. Seminars in Immunopathology 37(1): 1-3, 2015

Adaptative immunity and pathophysiology of multiple sclerosis. La Revue de Medecine Interne 34(8): 479-486, 2014

Pathophysiology of inflammation and tissue injury in multiple sclerosis: what are the targets for therapy. Journal of the Neurological Sciences 306(1-2): 167-169, 2011

A biochemical basis for the actions of lithium on behavior and on immunity relapsing and remitting disorders of inflammation and immunity such as multiple sclerosis or recurrent herpes as manic depression of the immune system. Medical Hypotheses 7(7): 891-906, 1981

Gut microbiota in multiple sclerosis: possible influence of immunomodulators. Journal of Investigative Medicine 63(5): 729-734, 2016

Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. Immunology and Allergy Clinics of North America 29(2): 309-320, 2009

Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. Neurologic Clinics 24(3): 507-519, 2006

The influence of interferon β-1b on gut microbiota composition in patients with multiple sclerosis. Neurologia 2018, 2018

The influence of sodium on pathophysiology of multiple sclerosis. Neurological Sciences 38(3): 389-398, 2017

Multiple Sclerosis: Progress and Problems || The Pathophysiology of Multiple Sclerosis: The Mechanisms Underlying the Production of Symptoms and the Natural History of the Disease. Philosophical Transactions Biological Sciences 354(1390): 1649-1673, 1999

Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis. Neurodegenerative Disease Management 5(6 Suppl): 15-17, 2016

The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis. Sleep Medicine Reviews 41: 255-265, 2018

Influence of genetic factors on cell-mediated and humoral immunity in multiple sclerosis. Israel Journal of Medical Sciences 25(12): 682-685, 1989

Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. Journal of Immunology 177(6): 4196-4202, 2006

Role of the microbiota in immunity and inflammation. Cell 157(1): 121-141, 2014